House · Engrossed · 2025-2026 Regular Session
HB 373: Insurance; annual prostate cancer screenings for certain men; require major medical coverage
Last action March 3, 2025 · Senate Read and Referred
House Bill 373 would require Georgia health insurance plans to cover annual prostate cancer screenings for men considered at high risk, starting with policies issued or renewed on or after January 1, 2026.
The summaries below were written by an AI model (claude-sonnet-5) from the text of the bill and are not part of it. Quote the text, not the summary. The stored text is the Comm Sub version, the latest the General Assembly's website lists.
In plain language
Currently Georgia law does not specifically require health insurance plans to cover prostate cancer screenings. House Bill 373 adds a new section to Georgia's insurance code requiring 'health benefit policies,' meaning most individual and group major medical plans sold in the state, to cover annual prostate cancer screenings for men defined as high risk. The bill defines high risk to include men aged 40 to 49 with a family history of prostate cancer, all men 50 and older, and any other men a physician determines to be at risk. It also defines what counts as a family history, including relatives diagnosed with, who died from, or who carry genetic markers linked to prostate cancer. Required screenings must include both a digital rectal examination and a prostate-specific antigen (PSA) blood test. The law would take effect as soon as the Governor signs it and would apply to insurance policies issued or renewed on or after January 1, 2026.
What the bill does
- Adds a new Code section (O.C.G.A. § 33-24-59.34) requiring major medical health insurance policies to cover annual prostate cancer screenings for high-risk men.
- Defines 'high risk' to include men 40-49 with a family history of prostate cancer, all men 50 and older, and other men a physician identifies as at risk.
- Defines 'family history' to cover first-degree relatives diagnosed with, killed by, or genetically linked to prostate cancer.
- Specifies the required screening must include both a digital rectal exam and a prostate-specific antigen (PSA) test.
- Applies the requirement to insurance policies issued, delivered, or renewed on or after January 1, 2026.
Who it affects
Men insured under individual or group major medical health plans in Georgia, especially those 50 and older or with a family history of prostate cancer, along with the health insurance companies, HMOs, and other insurers that must provide this coverage under Georgia law.
Why it matters
Men who fall into the bill's high-risk categories would no longer have to pay out of pocket for annual prostate cancer screenings, since insurers would be required to cover both the rectal exam and PSA test. This could make early detection more accessible for men most likely to develop the disease.
Key provisions
- Section 1 adds new Code section 33-24-59.34, defining 'health benefit policy' broadly to include most individual and group major medical insurance products sold in Georgia.
- Section 1 defines 'men with a family history of prostate cancer' based on a first-degree relative's diagnosis, death, related cancer diagnosis, or genetic risk marker.
- Section 1 defines 'men with a high risk for prostate cancer' as those 40-49 with a family history, all men 50 and older, or others identified by a physician.
- Section 1 requires covered screenings to include both a digital rectal examination and a prostate-specific antigen test.
- Section 2 sets the effective date as upon the Governor's approval (or becoming law without it) and applies the requirement to policies issued or renewed on or after January 1, 2026.
From the bill
“A health benefit policy shall provide coverage for annual prostate cancer screenings for men with a high risk for prostate cancer. Such coverage shall include a digital rectal examination and a prostate-specific antigen test.”
“Men with a high risk for prostate cancer' means: (A) Men with a family history of prostate cancer who are 40 to 49 years of age; (B) Men who are 50 years of age and older; and (C) Other men, as may be determined by a physician.”
Status timeline
- Senate Read and Referred (Senate)
- House Passed/Adopted By Substitute (House)
- House Third Readers (House)
- House Committee Favorably Reported By Substitute (House)
- House Second Readers (House)
- House First Readers (House)
- House Hopper (House)
Sponsors
- Lydia Glaize (D, HD-67)
- Mark Newton (R, HD-127)
- Sharon Cooper (R, HD-45)
- Billy Mitchell (D, HD-88)
- Miriam Paris (D, HD-142)
- Spencer Frye (D, HD-122)
Votes
- House voteFebruary 28, 2025
164 yea, 1 nay (5 not voting, 10 excused)
Topics
- prostate cancer screening
- health insurance coverage
- men's health
- cancer prevention